Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.

Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (7)

    1. Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats 2026-10-01 · Expand citations
    2. Psilocybin restores spatial memory but not fronto-hippocampal synchrony in a rat model of Alzheimer's disease 2026-10-01 · Expand citations
    3. Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review 2026-09-10 · Expand citations
    4. Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex 2026-07-28 · Expand citations
    5. Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review 2026-07-01 · Expand citations
    6. PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION 2026-01-28 · Expand citations
    7. Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress 2026-01-02 · Expand citations